Single-Photon Emission Computed Tomography Market Outlook, Prospects and Growth Assessment 2030
Growing Prevalence of
Neurodegenerative Disorders to Drive Single Photon Emission Computed Tomography
(SPECT) Market
What is single photon emission computed
tomography? What is it used for? What are the major drivers and restraints
affecting the global market for single photon emission computed tomography?
Find out the answers to these questions and more in the following writeup.
In addition, the global Single-Photon Emission
Computed Tomography Market is projected to reach USD 1.93 Billion by 2030 at 6.10% CAGR during the forecast
period 2022-2030.
Single photon emission
computed tomography: Introduction
Single photon emission computed tomography
(SPECT) is a nuclear medicine technology used for topographical purposes, i.e.
for imaging internal organs to check for signs of disease. In single photon
emission computed tomography, a radioligand is prepared and injected into the
patient’s body. This radioligand attaches to a predetermined set of tissues and
provides 3D images of the said tissues. Sometimes, a simple soluble dissolved
ion such as an isotope of gallium is also used for Single-Photon Emission
Computed Tomography Market. Single photon emission computed tomography is
similar to scintigraphy, in that both use gamma rays for imaging, but single
photon emission computed tomography is capable of producing true 3D
information.
The growing demand for 3D medical imaging has
been a defining feature of the global healthcare sector in recent years. 3D
medical imaging provides physicians with accurate images of the diseased part,
allowing them to take well-informed decisions. 3D medical imaging has been of
major help in identifying bone diseases, cardiac diseases, cancer, and other
diseases. 3D medical imaging is also crucial in making surgical decisions, as a
clear, accurate picture of the diseased organ or tissue is available to the
physicians.
Key players
Some of the global Single-Photon Emission
Computed Tomography Market Players Analysis are
GE Healthcare, Siemens Healthcare, Koninklijke
Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum
Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing
Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.,
PNPMedM, NuCare Inc.,
Segmentation
The spect scan for psychiatric diagnosis global
Single-Photon Emission Computed
Tomography Market Insights is segmented
·
on the basis of type, application, end-users. The Single-Photon Emission Computed Tomography
(SPECT) market, by type, the market is segmented into hybrid SPECT systems,
and standalone SPECT systems.
·
On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is
bifurcated into oncology, cardiology, neurology, and others.
·
On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centres,
academic & research centres, and others.
·
On the basis of region, the global Single-Photon Emission Computed Tomography (SPECT) market
is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and
Africa. The Americas is sub-segmented into North America and South America. The
North American region is further segmented into the US and Canada. The European
region is divided into two, namely, Western Europe and Eastern Europe. Western
Europe is further classified into Germany, Italy, France, the UK, Spain, and
the rest of Western Europe. The Asia-Pacific region is sub-segmented into
Japan, China, India, Australia, the Republic of Korea, and the rest of
Asia-Pacific. The Middle Eastern and African region is sub-segmented into the
United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the
Middle East and Africa.
Single photon emission
computed tomography: Major drivers and restraints
The growing prevalence of cancer is likely to
be a major driver for the global single photon emission computed tomography
market over the forecast period. Tumors can be very accurately imaged by single
photon emission computed tomography, allowing surgeons to make well-informed
choices and decisions about where to incise and how to remove the tumors.
Cancer has become a major challenge for the healthcare sector, with the
unavailability of tools to diagnose tumors early on proving to be a vital
hindrance.
The growing demand for functional brain imaging
is also likely to be a major driver for the global single photon emission
computed tomography market over the forecast period. Functional brain imaging
can be carried out easily by single photon emission computed tomography with
the help of a technetium-based nuclear isomer, which emits gamma rays. The
technetium tracer is taken up in the brain proportional to the blood flow,
allowing easy measurements of the local blood flow dynamics inside the brain.
As the blood flow dynamics inside a brain are closely related to brain function
and health, accurate predictions and calculations can be made regarding brain
health, using single photon emission computed tomography. The growing
prevalence of neurodegenerative diseases has been a major driver for functional
brain imaging and is likely to remain a major driver for the single photon
emission computed tomography market over the forecast period.
The growing geriatric population is also thus
likely to be a major driver for the global single photon emission computed
tomography market. Geriatric individuals are more likely to suffer from
neurodegenerative diseases and thus require single photon emission computed
tomography. This is a major driver for the global single photon emission
computed tomography market.
Single photon emission
computed tomography: Regional Analysis
The Americas region
dominates the global Single-Photon Emission
Computed Tomography Market Outlook owing to the presence
of major market participants and a sophisticated healthcare infrastructure. The
comparatively higher adoption of advanced nuclear medicine tomographic imaging
techniques in the U.S. and Canada is also a major driver for the global single
photon emission computed tomography market.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment